NEXGEL, Inc.
Healthcare sector | Medical Instruments & Supplies industry
Metrics for NXGL
| Price | $0.51 |
|---|---|
| Shares Outstanding | 8.85M |
| All-Time Low | $1.09 |
| 52-Week Low | $1.18 |
Balance Statement Metrics
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $-0.14 |
| Net Tangible Assets / Share | $0.35 |
| Shares Outstanding Ave Change (Annual) | 11.09% |
| Shares Δ YoY | 33.03% |
| Avg CA Burn (Annual %) | -25.85% (as of 4-12-2026) |
| Avg CA Burn (Quarterly %) | -1.86% (as of 4-12-2026) |
Earning Metrics
| Max Earning Power / Share | $-0.56 |
|---|---|
| Adjusted Earning Power |
$-1.04
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
⇒ adjustedEarningPower = ((-970,000 / 0.105) / 8,849,665) = -1.0439 |
| Non-Cash Charges to Market Cap |
8.93%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 0 (as of 4-12-2026) |
| Avg EBITDA (5Q) | 0 (as of 4-12-2026) |
| Avg Net Income (5Y) | -3.9M (as of 4-12-2026) |
| Avg Net Income (5Q) | -770K (as of 4-12-2026) |
Indicators
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 4-12-2026 |
| Consecutive Years Paid | No | 4-12-2026 |
| Pays Dividend | No | 4-12-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | No | 4-12-2026 |
| Net Income Positive | No | 4-12-2026 |
| Current Dividend Streak | No | 4-12-2026 |
Metric History Explorer
Pick a metric to view its history table and chart.
Tangible Book Value Per Share History
Formula: Tangible Book Value / shares from balance statements. Includes 6 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $0.33 | 2.6M ($2,650,000) | 8.1M (8,143,133) |
| 2025-09-30 | Quarterly | $0.41 | 3.3M ($3,346,000) | 8.1M (8,142,766) |
| 2025-06-30 | Quarterly | $0.37 | 2.8M ($2,799,000) | 7.7M (7,654,537) |
| 2025-03-31 | Quarterly | $0.43 | 3.3M ($3,306,000) | 7.7M (7,654,037) |
| 2024-12-31 | Quarterly | $0.50 | 3.8M ($3,820,000) | 7.6M (7,638,497) |
| 2024-12-31 | Annual | $0.50 | 3.8M ($3,820,000) | 7.6M (7,638,497) |
| 2024-09-30 | Quarterly | $0.40 | 2.7M ($2,724,000) | 6.8M (6,790,777) |
| 2023-12-31 | Annual | $0.56 | 3.2M ($3,243,000) | 5.7M (5,741,838) |
| 2022-12-31 | Annual | $1.31 | 7.3M ($7,306,000) | 5.6M (5,577,916) |
| 2021-12-31 | Annual | $2.11 | 11.7M ($11,741,000) | 5.6M (5,572,234) |
Revenue History (Annual)
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 8.7M ($8,688,000) |
| 2023-12-31 | 4.1M ($4,089,000) |
| 2022-12-31 | 2M ($2,048,000) |
| 2021-12-31 | 1.6M ($1,551,000) |
Dividend Payments
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
Shares Outstanding Changes
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-05-05 | 8,849,665 | +373,972 |
| 2026-04-06 | 8,475,693 | +332,560 |
Short Interest Changes
Latest short-interest change: 335,976 shares (4.50% of float) | Days to cover: 0.99
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-05-12 | 335,976 shares | +214,166 | +175.82% |
| 2026-04-27 | 121,810 shares | +36,732 | +43.17% |
| 2026-04-17 | 85,078 shares | -115,031 | -57.48% |
| 2026-03-25 | 200,109 shares | +195,990 | +4758.19% |
| 2026-03-12 | 4,119 shares | +1,726 | +72.13% |
| 2026-02-27 | 2,393 shares | +1,220 | +104.01% |
| 2026-02-11 | 1,173 shares | -7,850 | -87.00% |
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| 2026-04-21 | 3,656,515 | 8,475,693 | 43.14% | $0.74 |
| 2026-03-10 | 6,968,954 | 8,143,133 | 85.58% | $0.95 |
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.